Global Information
회사소개 | 문의 | 비교리스트

세계의 암 면역치료 시장(2022년)

Cancer Immunotherapy Global Market Report 2022

리서치사 The Business Research Company
발행일 2022년 09월 상품코드 1122677
페이지 정보 영문 175 Pages 배송안내 2-3일 (영업일 기준)
가격
US $ 5,000 ₩ 7,234,000 PDF (Single User License)
US $ 7,500 ₩ 10,851,000 PDF (Site License)
US $ 10,000 ₩ 14,469,000 PDF (Enterprise License)


세계의 암 면역치료 시장(2022년) Cancer Immunotherapy Global Market Report 2022
발행일 : 2022년 09월 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 암 면역치료 시장 규모는 2021년 777억 2,000만 달러에서 2022년에는 857억 달러로, CAGR 10.27%로 성장할 것으로 예측됩니다. 시장은 2026년까지 CAGR 14.08%를 나타내고, 1,451억 6,000만 달러에 달할 것으로 예측됩니다.

북미는 암 면역치료 시장에서 최대 지역이며, 또한 예측기간에 가장 빠르게 성장하는 지역이 될 것으로 예상됩니다.

암 이환율 상승은 암 면역치료 시장을 추진할 것으로 예상됩니다. 이러한 암 환자 증가는 암 면역치료 수요를 증가시킬 것으로 예상됩니다. 따라서 예측기간 중 암 이환율 증가에 의해 암 면역치료 수요가 증가할 것으로 예상됩니다.

암 면역치료에 이용되는 첨단 기술은 암 면역치료 시장에서 인기를 얻고 있는 주요 동향입니다. 면역종양학, 동결융해괴사요법, 골수이식, 방사선 치료 등 다양한 요법이나 기술을 이용해 면역계가 종양을 식별해 공격하기 위한 신기술과 다양한 치료법이 급증하고 있습니다. 이러한 기술은 암 치료와 치유에 큰 차이를 가져올 수 있습니다.

목차

제1장 주요 요약

제2장 암 면역치료 시장 특징

제3장 암 면역치료 시장 동향과 전략

제4장 COVID-19가 암 면역치료에 미치는 영향

제5장 암 면역치료 시장 규모와 성장

  • 세계의 시장 실적(금액)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 세계의 시장 예측(금액)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 암 면역치료 시장 세분화

  • 세계의 시장 실적과 예측(금액) : 제품별
  • 단일클론항체
  • 체크포인트 억제제
  • 면역조절제
  • 백신
  • 세포 치료
  • 세계의 시장 실적과 예측(금액) : 용도별
  • 폐암
  • 유방암
  • 대장암
  • 흑색종
  • 전립선암
  • 다발성 골수종
  • 세계의 시장 실적과 예측(금액) : 최종사용자별
  • 병원
  • 암연구센터
  • 진료소

제7장 암 면역치료 시장 지역·국가 분석

  • 세계의 시장 실적과 예측(금액) : 지역별
  • 세계의 시장 실적과 예측(금액) : 국가별

제8장 아시아태평양의 암 면역치료 시장

  • 시장 개요
  • 지역 정보, COVID-19의 영향, 시장 정보, 배경 정보, 정부 정책, 규제, 규제기관, 주요 단체, 과세, 법인세 구조, 투자, 주요 기업
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제9장 중국의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제10장 인도의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제11장 일본의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제12장 호주의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제13장 인도네시아의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제14장 한국의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제15장 서유럽의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제16장 영국의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제17장 독일의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제18장 프랑스의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제19장 동유럽의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제20장 러시아의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제21장 북미의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제22장 미국의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제23장 남미의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제24장 브라질의 암 면역치료 시장

  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제25장 중동의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제26장 아프리카의 암 면역치료 시장

  • 시장 개요
  • 시장 실적과 예측(금액) : 제품별
  • 시장 실적과 예측(금액) : 최종사용자별

제27장 암 면역치료 시장 경쟁 상황과 기업 개요

  • 암 면역치료 시장 경쟁 상황
  • 암 면역치료 시장 기업 개요
    • Amgen
    • AstraZeneca
    • F. Hoffman La-Roche
    • Bayer AG
    • Eli Lilly and Company

제28장 암 면역치료 시장의 주요 인수합병

제29장 암 면역치료 시장 향후 전망과 잠재성 분석

제30장 부록

KSM 22.09.15

“Cancer Immunotherapy Global Market Report 2022 ” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cancer immunotherapy market market.

This report focuses on cancer immunotherapy market market which is experiencing strong growth. The report gives a guide to the cancer immunotherapy market market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the cancer immunotherapy market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Cancer Immunotherapy Market market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider cancer immunotherapy market market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The cancer immunotherapy market market section of the report gives context. It compares the cancer immunotherapy market market with other segments of the cancer immunotherapy market market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cancer immunotherapy market indicators comparison.

Scope

Markets Covered:

  • 1) By Product: Monoclonal Antibodies; Checkpoint Inhibitors; Immunomodulators; Vaccines; Cell Therapy
  • 2) By Application: Lung Cancer; Breast Cancer; Colorectal Cancer; Melanoma; Prostate Cancer; Multiple Myeloma
  • 3) By End User : Hospitals; Cancer Research Centers; Clinics
  • Companies Mentioned: Amgen; AstraZeneca; F. Hoffman La-Roche; Bayer AG; Eli Lilly and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Executive Summary

Major players in the cancer immunotherapy market are: Amgen, AstraZeneca, F. Hoffman La-Roche, Bayer AG, Eli Lilly and Company, Pfizer Inc., Merck KGAA, Novartis AG., GlaxoSmithKline PLC, Janssen Global Services, OSE Immunotherapeutics, Celgene Corporation, Seattle Genetics Inc., AMAL Therapeutics, and Bluebird bio.

The global cancer immunotheraphy market is expected to grow from $77.72 billion in 2021 to $85.70 billion in 2022 at a compound annual growth rate (CAGR) of 10.27%. The cancer immunotheraphy market is expected to reach $145.16 billion in 2026 at a CAGR of 14.08%.

The cancer immunotherapy market consists of sales of cancer immunotherapy by entities (organizations, sole traders, and partnerships) that refers to a type of cancer treatment in which the body's immune system is used to prevent, control, and eliminate cancer. Immunotherapy aims to boost immune cells to fight cancer and provide the body with additional components to stimulate the body's immune system. Cancer immunotherapy comes in various forms, such as cytokines and vaccines, adoptive cell therapies, oncolytic viruses, tumor-infecting viruses, and others.

The main types of products of cancer immunotherapy are monoclonal antibodies, checkpoint inhibitors, immunomodulators, vaccines, and cell therapy. Monoclonal antibodies are man-made proteins that function in the immune system like human antibodies. Cancer immunotherapy is used to treat lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, and multiple myeloma. These are used in hospitals, cancer research centers, and clinics.

North America was the largest region in the cancer immunotherapy market and is also expected to be the fastest-growing region in the forecast period. The regions covered in cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The cancer immunotheraphy market research report is one of a series of new reports from The Business Research Company that provides cancer immunotheraphy market statistics, including cancer immunotheraphy industry global market size, regional shares, competitors with a cancer immunotheraphy market share, detailed cancer immunotheraphy market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotheraphy industry. This cancer immunotheraphy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rise in cancer incidence is expected to propel the cancer immunotherapy market. The factors contributing to the growth in cancer cases across the globe include tobacco, alcohol, obesity, a sedentary lifestyle, and environmental factors. This growth in cancer cases is expected to boost demand for cancer immunotherapies, as patients are increasingly investing in medical treatments with greater recovery and minimal pain. For instance, according to the report published by National Cancer Institute (USA), in 2020, cancer was among the leading causes of death worldwide, with an estimated 1,806,590 new cases and 606,520 deaths due to cancer in the United States. By 2040, the number of cancer cases per year is expected to be 29.5 million, with 16.4 million cancer-related deaths. Therefore, the increase in cancer incidence is expected to boost demand for cancer immunotherapy during forecast period.

The advanced technologies used in cancer immunotherapy are a key trend gaining popularity in the cancer immunotherapy market. There has been a surge of new technologies and various therapies to help the immune system identify and attack tumors using different therapy and technology such as immuno-oncology, cryoablation, bone marrow transplant, and radiation therapy. These technologies can make a significant difference in cancer treatment and cure. For instance, in 2019, Roche Holding AG, a Swiss healthcare company, received approval to launch its new cancer immunotherapy atezolizumab in India. It is beneficial for patients with small-cell lung cancer.

In July 2019, Boehringer Ingelheim, a German-based pharmaceutical company, acquired AMAL Therapeutics for an undisclosed amount. With this acquisition, Boehringer Ingelheim is trying to enrich the platform for expanding its cancer immunology portfolio with novel cancer vaccines, including immuno-oncology therapies that use cutting-edge scientific discoveries and their applications. AMAL Therapeutics is a Swiss biotechnology company focused on cancer immunotherapy and therapeutic cancer vaccines.

The countries covered in the cancer immunotherapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Table of Contents

1. Executive Summary

2. Cancer Immunotherapy Market Characteristics

3. Cancer Immunotherapy Market Trends And Strategies

4. Impact Of COVID-19 On Cancer Immunotherapy

5. Cancer Immunotherapy Market Size And Growth

  • 5.1. Global Cancer Immunotherapy Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Cancer Immunotherapy Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Cancer Immunotherapy Market Segmentation

  • 6.1. Global Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Monoclonal Antibodies
  • Checkpoint Inhibitors
  • Immunomodulators
  • Vaccines
  • Cell Therapy
  • 6.2. Global Cancer Immunotherapy Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Multiple Myeloma
  • 6.3. Global Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hospitals
  • Cancer Research Centers
  • Clinics

7. Cancer Immunotherapy Market Regional And Country Analysis

  • 7.1. Global Cancer Immunotherapy Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Cancer Immunotherapy Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Cancer Immunotherapy Market

  • 8.1. Asia-Pacific Cancer Immunotherapy Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Cancer Immunotherapy Market

  • 9.1. China Cancer Immunotherapy Market Overview
  • 9.2. China Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Cancer Immunotherapy Market

  • 10.1. India Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Cancer Immunotherapy Market

  • 11.1. Japan Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Cancer Immunotherapy Market

  • 12.1. Australia Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Cancer Immunotherapy Market

  • 13.1. Indonesia Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Cancer Immunotherapy Market

  • 14.1. South Korea Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Cancer Immunotherapy Market

  • 15.1. Western Europe Cancer Immunotherapy Market Overview
  • 15.2. Western Europe Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Cancer Immunotherapy Market

  • 16.1. UK Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Cancer Immunotherapy Market

  • 17.1. Germany Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Cancer Immunotherapy Market

  • 18.1. France Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.2. France Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Cancer Immunotherapy Market

  • 19.1. Eastern Europe Cancer Immunotherapy Market Overview
  • 19.2. Eastern Europe Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Cancer Immunotherapy Market

  • 20.1. Russia Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Cancer Immunotherapy Market

  • 21.1. North America Cancer Immunotherapy Market Overview
  • 21.2. North America Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Cancer Immunotherapy Market

  • 22.1. USA Cancer Immunotherapy Market Overview
  • 22.2. USA Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Cancer Immunotherapy Market

  • 23.1. South America Cancer Immunotherapy Market Overview
  • 23.2. South America Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Cancer Immunotherapy Market

  • 24.1. Brazil Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Cancer Immunotherapy Market

  • 25.1. Middle East Cancer Immunotherapy Market Overview
  • 25.2. Middle East Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Cancer Immunotherapy Market

  • 26.1. Africa Cancer Immunotherapy Market Overview
  • 26.2. Africa Cancer Immunotherapy Market, Segmentation By Product, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Cancer Immunotherapy Market, Segmentation By End User, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Cancer Immunotherapy Market Competitive Landscape And Company Profiles

  • 27.1. Cancer Immunotherapy Market Competitive Landscape
  • 27.2. Cancer Immunotherapy Market Company Profiles
    • 27.2.1. Amgen
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. AstraZeneca
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. F. Hoffman La-Roche
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Bayer AG
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Eli Lilly and Company
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Cancer Immunotherapy Market

29. Cancer Immunotherapy Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q